Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1995;26:1234-1239

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okudaira, Y.
Right arrow Articles by Sato, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okudaira, Y.
Right arrow Articles by Sato, K.

(Stroke. 1995;26:1234-1239.)
© 1995 American Heart Association, Inc.


Articles

Evaluation of the Acetazolamide Test

Vasoreactivity and Cerebral Blood Volume

Yojiro Okudaira, MD; Kuniaki Bandoh, MD; Hajime Arai, MD Kiyoshi Sato, MD

From the Department of Neurosurgery, Juntendo University, Tokyo, Japan.

Background and Purpose We evaluated the potential usefulness of the acetazolamide test by investigating whether acetazolamide vasoreactivity reflected the change in resting cerebral blood volume caused by compensatory vasodilation due to a decline in cerebral perfusion pressure.

Methods We measured resting and acetazolamide-activated cerebral blood flow with a stable xenon-enhanced CT system and resting cerebral blood volume with the subtraction technique using contrast-enhanced CT in 30 patients with various diseases. These parameters were measured in the anterior, middle, and posterior cerebral arterial territories of both hemispheres separately. We evaluated the statistical relationships between resting cerebral blood volume and vasoreactivity in these three territories, and the significance of the correlations was tested by ANOVA/ANCOVA to adjust for the double entries.

Results Significant negative linear relationships were demonstrated between the resting cerebral blood volume and the change in cerebral blood flow, expressed as a percentage induced by acetazolamide activation, for the anterior (r=-.607, P=.0004), middle (r=-.551, P=.0015), and posterior (r=-.523, P=.0078) cerebral arterial territories and between the resting cerebral blood volume and the increase in cerebral blood flow (absolute values) for the anterior (r=-.512, P=.0164) and middle (r=-.523, P=.0001) but not the posterior (r=-.571, P=.0563) cerebral arterial territories.

Conclusions The acetazolamide test appears to be useful for the investigation of compensatory vasodilation: the vasoreactivity can be calculated as the increased cerebral blood flow expressed as a percentage or an absolute value, which both reflect cerebral blood volume directly.


Key Words: acetazolamide • cerebral blood flow • cerebral blood volume • tomography




This article has been cited by other articles:


Home page
ImagingHome page
G TAN and T GODDARD
Neuroimaging applications of multislice CT perfusion
Imaging, June 1, 2007; 19(2): 142 - 152.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M l. Cour, J F Kiilgaard, T Eysteinsson, A K Wiencke, K Bang, J Dollerup, P K Jensen, and E Stefánsson
Optic nerve oxygen tension: effects of intraocular pressure and dorzolamide
Br. J. Ophthalmol., September 1, 2000; 84(9): 1045 - 1049.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
S. J. Schreiber, S. Gottschalk, M. Weih, A. Villringer, and J. M. Valdueza
Assessment of Blood Flow Velocity and Diameter of the Middle Cerebral Artery during the Acetazolamide Provocation Test by Use of Transcranial Doppler Sonography and MR Imaging
AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1207 - 1211.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Wiart, Y. Berthezene, P. Adeleine, P. Feugier, P. Trouillas, J.-C. Froment, and N. Nighoghossian
Vasodilatory Response of Border Zones to Acetazolamide Before and After Endarterectomy : An Echo Planar Imaging-Dynamic Susceptibility Contrast-Enhanced MRI Study in Patients With High-Grade Unilateral Internal Carotid Artery Stenosis
Stroke, July 1, 2000; 31(7): 1561 - 1565.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. G. Nabavi, A. Cenic, R. A. Craen, A. W. Gelb, J. D. Bennett, R. Kozak, and T.-Y. Lee
CT Assessment of Cerebral Perfusion: Experimental Validation and Initial Clinical Experience
Radiology, October 1, 1999; 213(1): 141 - 149.
[Abstract] [Full Text]


Home page
StrokeHome page
R. Brilla, D. G. Nabavi, G. Schulte-Altedorneburg, V. Kemeny, D. Reichelt, S. Evers, U. Schiemann, and I.-W. Husstedt
Cerebral Vasculopathy in HIV Infection Revealed by Transcranial Doppler : A Pilot Study
Stroke, April 1, 1999; 30(4): 811 - 813.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. T. Ulrich, S. Kroppenstedt, A. Heimann, O. Kempski, and B. G. Lyeth
Laser-Doppler Scanning of Local Cerebral Blood Flow and Reserve Capacity and Testing of Motor and Memory Functions in a Chronic 2-Vessel Occlusion Model in Rats • Editorial Comment
Stroke, November 1, 1998; 29(11): 2412 - 2420.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. Okudaira, H. Arai, and K. Sato
Cerebral Blood Flow Alteration by Acetazolamide During Carotid Balloon Occlusion : Parameters Reflecting Cerebral Perfusion Pressure in the Acetazolamide Test
Stroke, April 1, 1996; 27(4): 617 - 621.
[Abstract] [Full Text]